Drug application
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM (DIATRIZOATE MEGLUMINE, DIATRIZOATE SODIUM)
Drugs@FDA ANDA 214201 · ADAPTIS
Key facts
| Drug name | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM |
|---|---|
| Active ingredients | DIATRIZOATE MEGLUMINE, DIATRIZOATE SODIUM |
| Application type | ANDA |
| Application number | 214201 |
| Company | ADAPTIS |
| Dosage forms | SOLUTION, ORAL, RECTAL |
| Strength | 66%;10% |
| Marketing status | Prescription |
| TE codes | AA |
| Reference listed drug | No |
| Latest submission status date | Jun 27, 2022 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.